M
MitrAssist
Minimally invasive approach to Mitral heart value surgery
About MitrAssist
MitrAssist is a medical device company specializing in minimally invasive treatments for Mitral Regurgitation (MR), a condition affecting the heart's mitral valve. The company targets patients who are unable to undergo risky open-heart surgery, providing a safer alternative with its innovative mitral valve implant. This implant works in harmony with the natural mitral valve, preserving its functionality and adapting to various anatomical shapes. MitrAssist operates in the healthcare market, specifically focusing on cardiology and medical devices. The business model revolves around the development, manufacturing, and distribution of its proprietary mitral valve implants to hospitals and healthcare providers. Revenue is generated through the sale of these implants and associated medical services. The company's solution is designed to be long-lasting, significantly reducing both the procedure and recovery times for patients, making it suitable for individuals of all ages.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2009
- Headquarters
- Misgav, Israel
- Employees
- 3
- Open positions
- None listed
- Dealroom signal
- 59.9/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Surgery, Cardiology and cardiovascular, Biomaterials, Valves, Biotech and Pharma, Hard Tech
- Business model
- Manufacturing
- Client focus
- b2b
- Investment activity
- 1 company, latest Jun 2021
- Capital deployed
- $32M
- Preferred round
- SERIES B
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Sep 2023 | $100M | $400M | Hefei Industry Investment Group · Hefei Haiheng Holdings · Jiading District (Shanghai) · 6 Dimensions Capital | ↗ |
| SERIES BOther financing | Dec 2020 | $50M | $300M | CICC · Ping An Group · CITIC Securities · Shanghai Fosun Pharmaceutical | — |
Growth signals
Latest recorded traffic for MitrAssist is 150 monthly website visits, up 7.1% over the last three months. MitrAssist's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
CICC
CITIC Securities
6 Dimensions Capital
Centurium Capital
Series B and later6 investors entered at this stage
Fosun Group
Shanghai Fosun Pharmaceutical
Ping An Group- HGHefei Industry Investment Group
- HHHefei Haiheng Holdings
- J(Jiading District (Shanghai)
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about MitrAssist on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See MitrAssist’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.